In memoriam: Peter Geiduschek
Peter Geiduschek, a pioneering researcher in DNA structure and gene expression at the University of California, San Diego and a member of the American Society for Biochemistry and Molecular Biology since 1963, died April 8, 2022, just shy of his 94th birthday, the ASBMB learned recently.

Geiduschek was born April 11, 1928, in Vienna. In 1939, after the Nazis annexed Austria, he was among the Jewish children transported to safety in England. There he earned his school certificate before rejoining his parents who had fled to New York. He completed his undergraduate degree in chemistry at Columbia University and earned his Ph.D. in physical chemistry at Harvard University.
After serving two years in the U.S. Army at the biochemistry department of Walter Reed Hospital in Washington, D.C. and working for the Committee on Biophysics at the University of Chicago for a decade, he joined the faculty at UC San Diego in 1970, where he remained until his retirement in 2014.
Geiduschek’s research focused on genetic and transcriptional regulation in phages, yeast and archaea. He made seminal contributions to the field’s understanding of the physical properties of DNA. Specifically, he was the first to show that DNA denaturation is reversible and he coined the term “chaotropic,” which is used today to describe how salts can destabilize DNA and its hydrogen bonds by displacing water. In addition, his findings helped elucidate how viruses take over host machinery. Geiduschek also made major discoveries on RNA polymerases and the mechanisms of transfer RNA synthesis.
He was an elected member of the National Academy of Sciences and the American Academy of Arts and Sciences and a fellow of the American Association for the Advancement of Science and the American Academy of Microbiology.
In Geiduschek’s UC San Diego obituary, James T. Kadonaga wrote: “(W)ith his wit, charm and warm and caring personality, he was a much-loved colleague. We thus honor and will fondly remember a remarkable and singular individual who has provided much of the basic knowledge of DNA and gene expression that we enjoy today and significantly and selflessly contributed to the establishment of UC San Diego as one of the premier research universities in the world.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.